ArcAroma AB: 201023 Extended evaluation agreement on oliveCEPT® in China
Press release 2019-10-23
ArcAroma has extended its existing oliveCEPT® evaluation agreement with one of the leading olive oil producers in China. Due to the customer's recent adjustments in the production line, a new evaluation is now being started. By placing oliveCEPT® before malaxation, instead of afterwards, the extraction of Extra Virgin Olive Oil (EVOO) is estimated to be able to increase by the corresponding five to ten percent, which also contributes to a more efficient production process and an improved quality of the end product.
The customer will optimize process time for shorter malaxation time during the season and the goal is to reach 10 to 15 minutes, i.e. a process efficiency of 30 minutes. If the agreed targets of the production period are achieved, the sales contract will amount to an order value of 150 000 EUR in the first or second quarter of 2021. In the previous evaluation period, a production increase was noted when oliveCEPT® was placed before the malaxer, but the customer initially notes that the production increase becomes more significant with a placement before the malaxer. If the targets are met during the production period, the evaluation will result in a sales agreement amounting to EUR 150,000 during the first or second quarter of 2021. Details of targets will not be disclosed at this time.
The customer is located in the largest production area for olive oil, which accounts for 80 percent of the total olive oil production in China. The original evaluation agreement was signed in September 2019. ArcAroma Shanghai Ltd is responsible for the overall project management, which includes installation, operation, personnel training and testing of the machine. China is a growing EVOO market with a larger number of olive trees than there are in Andalusia in Spain. ArcAroma's goal is for oliveCEPT® to become the technology standard in a growing olive oil market.
For more information, please contact:
Johan Möllerström, CEO
(+46) 768 – 86 81 78
This information is such information that Arc Aroma Pure AB (publ) is obliged to make public pursuant to the EU Market Abuse Regulation. The information was submitted for publication, through the agency of the contact person set above, at October 23, 2020 at 10.00 CEST.
About ArcAroma AB (publ)
ArcAroma has developed a patented technology that controls and applies electrical pulses to optimize various biological processes. The CEPT® platform, which is a high-voltage generator combined with a treatment chamber, uses the technology within FoodTech for increased extraction from the raw material and extended shelf-life and increased quality of the final product. Within CleanTech, the CEPT® platform is used for sewage sludge treatment and biogas production. The platform uses short-term high-voltage pulses (PEF) that crush the cell membrane and eliminate unwanted microorganisms.
Our vision is to contribute to a sustainable world by offering efficient green cutting-edge technology that is easy to use in the areas of FoodTech and CleanTech.
To view this piece of content from www.globenewswire.com, please give your consent at the top of this page.
One Liberty Plaza - 165 Broadway
NY 10006 New York
GlobeNewswire is one of the world's largest newswire distribution networks, specializing in the delivery of corporate press releases financial disclosures and multimedia content to the media, investment community, individual investors and the general public.
Subscribe to releases from GlobeNewswire
Subscribe to all the latest releases from GlobeNewswire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from GlobeNewswire
Leading Edge Materials Reports Quarterly Results to April 30, 202123.6.2021 22:15:00 CEST | Press release
Vancouver, June 23, 2021 – Leading Edge Materials Corp. (“Leading Edge Materials” or the “Company”) (TSXV: LEM) (Nasdaq First North: LEMSE) (OTCQB: LEMIF) announces second quarter results for the period ending April 30, 2021. All references to dollar amounts in this release are in Canadian dollars unless otherwise specified. Highlights During and After the Quarter During the three months ended April 30, 2021 the Company: Appointed Mr. Sanjay Swarup as new Chief Financial Officer on March 1, 2021Held its Annual General Meeting of Shareholders on April 21, 2021, where shareholders voted in favour of setting the number of directors at three and for the re-election of all director nominees. In addition, shareholders also approved the ratification of the Company’s 10% rolling stock option plan and the appointment of D&H Group LLP, Chartered Professional Accountants, as the auditors of the Company for the ensuing year and the authorization for the directors of the Company to fix their remune
MicroStar Promotes Glen Opp to President, Kegstar Division to Further Accelerate Global Growth23.6.2021 21:00:00 CEST | Press release
DENVER, June 23, 2021 (GLOBE NEWSWIRE) -- MicroStar Logistics, the leading diversified keg solutions provider, today announces the promotion of Glen L. Opp to President, Kegstar Division. In addition to maintaining his role as COO of MicroStar Corporation, Glen will now be responsible for all aspects of MicroStar's newly acquired Kegstar business with expanding operations throughout the UK, Europe, Australia and New Zealand. Glen has vast experience in the beer industry and has worked with a wide variety of brewers ranging from small, start-up micros to the largest brewers in the world. In addition, Glen has significant international expertise and has led operations throughout the Americas, Europe and Asia. Since joining MicroStar in 2016, Glen has led many transformational projects including the build out of the largest, most efficient network of keg quality centers in the world. This network of facilities includes MicroStar newest 250,000 square foot, state-of-the-art operation in Te
Tecan expands its commercial reach, its capabilities and its US and Asia presence with the acquisition of Paramit Corporation23.6.2021 19:00:00 CEST | Press release
Tecan to acquireParamit Corporation, a leading OEMdeveloper and manufacturer of medical devices and life sciences instruments,for a total consideration of USD 1.0billion (CHF 920 million) In full year 2021, Paramit is expected to generate aroundUSD280min sales (CHF 257m)and around USD 50m EBITDA (CHF 46m),before acquisition-related costs Transaction expected to be immediately and significantly accretive to earnings per share (EPS) upon closingAdds complementary expertise, broadens design, development and manufacturing capabilitiesExpansion into the attractive and fast-growing medical device market segment, close to Tecan’s own core competenciesCombined entity with leading OEM offering, well diversified, differentiated and fully complementary portfolio of products and servicesSignificantly strengthens geographic footprint in the US, the largest life sciences and healthcare market in the world Männedorf, Switzerland, June 23 2021 – The Tecan Group (SIX Swiss Exchange: TECN) announced tod
PRESS RELEASE: Redeye’s initiating research coverage on SSH.COM has been published23.6.2021 17:13:20 CEST | Press release
Redeye’sinitiating research coverage on SSH.COM has been published Helsinki, Finland – June23rd, 2021– As announced on April 7th, 2021 the technology sector-focused Swedish investment bank Redeye (www.redeye.se) has initiated research coverage of SSH.COM. The first report is now available on their website through free registering (Redeye reporton SSH.COM). About SSH.COM SSH.COM helps organizations safeguard their mission-critical digital assets at rest, in transit and in use. We have 5,000+ customers worldwide, including 40 percent of Fortune 500 companies, and major organizations in Finance, Government, Retail, and Industries. We are committed to helping our customers secure their business in the age of hybrid cloud and distributed IT and OT solutions. Our Zero Trust solutions offer safe electronic communications, secure access to servers and between servers. Our teams in North America, Europe, Asia along with a global network of certified partners ensure customer success. The company
XBiotech Announces First Patient Enrolled in Clinical Trial Evaluating XB2001 for the Treatment of Pancreatic Cancer23.6.2021 14:30:00 CEST | Press release
XB2001 Is a Novel Therapy that Interrupts Inflammation to Potentially Block Growth and Spread of Tumors and to Reduce Toxicity of Chemotherapy Treatment AUSTIN, Texas, June 23, 2021 (GLOBE NEWSWIRE) -- XBiotech Inc. (NASDAQ: XBIT) has enrolled the first patient in its 1-BETTER study, a randomized, double-blind, placebo-controlled clinical study to evaluate XB2001 in combination chemotherapy for treatment of Pancreatic Cancer. XBiotech’s novel anti-cancer agent, XB2001, is being assessed in combination with ONIVYDE + 5-FU/LV chemotherapy regimens. Safety and tolerability of the regimen, as well as progression-free survival, overall survival and time-to-treatment-failure will be assessed in the study. XB2001 blocks inflammation pathways turned on by tumors that help tumors vascularize, spread and cause collateral damage to healthy tissues. By using XB2001 to block inflammation in pancreatic cancer, investigators also hope to see a reduction in serious adverse events and reduced hospitali
TGS Announces Acquisition of Three Polcarus 3D Multi-Client Surveys23.6.2021 13:44:41 CEST | Press release
OSLO, Norway (23 June 2021) – TGS ASA (‘TGS’), a global provider of energy data and intelligence, today announced that it has acquired three 3D multi-client seismic surveys of Polarcus Plc. (‘Polarcus’) covering a total of 12,200 square kilometers offshore Australia. In addition, Polarcus has permanently waived the revenue share rights associated with the multi-client library that TGS acquired in 2015. Polarcus has been eligible to 50% revenue share from the relevant datasets after accumulated revenues reached TGS’ minimum return requirements. Kristian Johansen, CEO at TGS, stated, “The transaction further enhances TGS’ position in certain prospective basins in Australia where many of our customers are actively exploring. Over the past six years, TGS has taken advantage of its strong financial position to acquire several multi-client libraries and single assets that have formed the basis for further development of the relevant basins, creating significant value both for our customers a
Benjamin Hill Appoints David Jones as Technical Advisor23.6.2021 13:30:00 CEST | Press release
VANCOUVER, British Columbia, June 23, 2021 (GLOBE NEWSWIRE) -- Benjamin Hill Mining Corp. (CSE: BNN) (OTCBB: BNNHF) (“BHM” or the “Company”) is pleased to announce the appointment of David M. Jones, M.Sc., as Technical Advisor to the company. Mr. Jones is a graduate of Dartmouth College, New Hampshire (B.Sc.) and the University of Arizona (M.Sc.). Mr. Jones has over 40 years of exploration experience throughout the Americas and is a foremost specialist on the Guerrero Gold Belt of Mexico. As a Project Manager and Chief Geologist for Teck Corp., he discovered the Los Filos deposit in 1995, and then led their successful bid to acquire the Morelos Norte reserve (El Limon/Los Guajes deposits – Torex Gold). Most recently, Mr. Jones was responsible for identifying the exploration targets that directly led to discovery of Gold Resource Corp's bonanza grade Au-Ag Switchback Mine in Oaxaca, Mexico. Dave is currently a director of Minaurum Gold, Madoro Metals, and private concern, Acapulco Gold.